Lithium perhydroantamanide complex (2:1): exposure of the peptide backbone in the analog of antamanide with antitoxic impotency.
The synthetic analog of antamanide in which all four phenylalanyl residues are hydrogenated to cyclohexylalanyl (Cha) residues, cyclic(Val-Pro-Pro-Ala-Cha-Cha-Pro-Pro-Cha-Cha), has a complete loss of antitoxic potency despite its ability to form ion complexes in the same manner as antamanide. The co...
Guardat en:
| Publicat a: | Proc Natl Acad Sci U S A |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
National Academy of Sciences
1985
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC390807/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3864151/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.82.21.7155 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|